XPNPEP2 and metastatic prostate carcinoma: In addition, we analyzed XPNPEP2 gene alterations using data extracted from the cBioPortal online analysis tool and found that metastatic prostate cancer has the highest frequency of XPNPEP2 gene amplification17,18.